842 related articles for article (PubMed ID: 24290461)
1. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
Blader JC; Pliszka SR; Kafantaris V; Foley CA; Crowell JA; Carlson GA; Sauder CL; Margulies DM; Sinha C; Sverd J; Matthews TL; Bailey BY; Daviss WB
J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1281-93. PubMed ID: 24290461
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
Blader JC; Schooler NR; Jensen PS; Pliszka SR; Kafantaris V
Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
[TBL] [Abstract][Full Text] [Related]
3. A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression.
Masi G; Manfredi A; Nieri G; Muratori P; Pfanner C; Milone A
J Clin Psychopharmacol; 2017 Oct; 37(5):590-594. PubMed ID: 28806385
[TBL] [Abstract][Full Text] [Related]
4. Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.
Blader JC; Pliszka SR; Kafantaris V; Foley CA; Carlson GA; Crowell JA; Bailey BY; Sauder C; Daviss WB; Sinha C; Matthews TL; Margulies DM
J Am Acad Child Adolesc Psychiatry; 2021 Feb; 60(2):236-251. PubMed ID: 32007604
[TBL] [Abstract][Full Text] [Related]
5. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.
Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG
J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437
[TBL] [Abstract][Full Text] [Related]
6. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder?
Aman MG; Bukstein OG; Gadow KD; Arnold LE; Molina BS; McNamara NK; Rundberg-Rivera EV; Li X; Kipp H; Schneider J; Butter EM; Baker J; Sprafkin J; Rice RR; Bangalore SS; Farmer CA; Austin AB; Buchan-Page KA; Brown NV; Hurt EA; Grondhuis SN; Findling RL
J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):47-60.e1. PubMed ID: 24342385
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Treatment Outcomes of Persistent Negative Mood Among Children with Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior.
Blader JC; Pliszka SR; Kafantaris V; Sauder C; Posner J; Foley CA; Carlson GA; Crowell JA; Margulies DM
J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):164-73. PubMed ID: 26745211
[TBL] [Abstract][Full Text] [Related]
8. Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression.
Joseph HM; Farmer C; Kipp H; Kolko D; Aman M; McGinley J; Arnold LE; Gadow KD; Findling RL; Molina BSG
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):90-99. PubMed ID: 30592635
[TBL] [Abstract][Full Text] [Related]
9. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD.
Blader JC; Pliszka SR; Jensen PS; Schooler NR; Kafantaris V
Pediatrics; 2010 Oct; 126(4):e796-806. PubMed ID: 20837589
[TBL] [Abstract][Full Text] [Related]
10. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.
Gadow KD; Arnold LE; Molina BS; Findling RL; Bukstein OG; Brown NV; McNamara NK; Rundberg-Rivera EV; Li X; Kipp HL; Schneider J; Farmer CA; Baker JL; Sprafkin J; Rice RR; Bangalore SS; Butter EM; Buchan-Page KA; Hurt EA; Austin AB; Grondhuis SN; Aman MG
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):948-959.e1. PubMed ID: 25151418
[TBL] [Abstract][Full Text] [Related]
11. Subgrouping children and adolescents with disruptive behaviors: symptom profiles and the role of callous-unemotional traits.
Rosa-Justicia M; Saam MC; Flamarique I; Borràs R; Naaijen J; Dietrich A; Hoekstra PJ; Banaschewski T; Aggensteiner P; Craig MC; Sethi A; Santosh P; Sagar-Ouriaghli I; Arango C; Penzol MJ; Brandeis D; Werhahn JE; Glennon JC; Franke B; Zwiers MP; Buitelaar JK; Schulze UME; Castro-Fornieles J
Eur Child Adolesc Psychiatry; 2022 Jan; 31(1):51-66. PubMed ID: 33147348
[TBL] [Abstract][Full Text] [Related]
12. Oppositional defiant disorder symptoms in relation to psychopathic traits and aggression among psychiatrically hospitalized children: ADHD symptoms as a potential moderator.
Becker SP; Luebbe AM; Fite PJ; Greening L; Stoppelbein L
Aggress Behav; 2013; 39(3):201-11. PubMed ID: 23436456
[TBL] [Abstract][Full Text] [Related]
13. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.
Farmer CA; Brown NV; Gadow KD; Arnold LE; Kolko DG; Findling RL; Molina BS; Buchan-Page KA; Rice RR; Bangalore SS; Bukstein O; Rundberg-Rivera EV; McNamara N; Aman MG
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):213-24. PubMed ID: 25885011
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
Pringsheim T; Hirsch L; Gardner D; Gorman DA
Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
[TBL] [Abstract][Full Text] [Related]
15. Emotional dysregulation and callous unemotional traits as possible predictors of short-term response to methylphenidate monotherapy in drug-naïve youth with ADHD.
Masi G; Fantozzi P; Muratori P; Bertolucci G; Tacchi A; Villafranca A; Pfanner C; Cortese S
Compr Psychiatry; 2020 Jul; 100():152178. PubMed ID: 32386957
[TBL] [Abstract][Full Text] [Related]
16. Combined pharmacotherapy-multimodal psychotherapy in children with Disruptive Behavior Disorders.
Masi G; Milone A; Manfredi A; Brovedani P; Pisano S; Muratori P
Psychiatry Res; 2016 Apr; 238():8-13. PubMed ID: 27086204
[TBL] [Abstract][Full Text] [Related]
17. Can children with callous and unemotional traits be treated successfully?
Newcorn JH
J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1257-9. PubMed ID: 24290458
[No Abstract] [Full Text] [Related]
18. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study.
Ricketts EJ; Sturm A; McMakin DL; McGuire JF; Tan PZ; Smalberg FB; McCracken JT; Colwell CS; Piacentini J
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):690-698. PubMed ID: 30388029
[No Abstract] [Full Text] [Related]
19. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
20. Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial.
Gadow KD; Brown NV; Arnold LE; Buchan-Page KA; Bukstein OG; Butter E; Farmer CA; Findling RL; Kolko DJ; Molina BS; Rice RR; Schneider J; Aman MG
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):469-78. PubMed ID: 27238065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
